| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 240 | 2.233 | 664 | 2.601 | 3.921 | 3.918 | 11.476 | 13.001 | 7.152 |
| Total Income - EUR | 31 | 303 | 2.233 | 664 | 3.975 | 3.921 | 3.918 | 11.476 | 13.001 | 7.152 |
| Total Expenses - EUR | 8.015 | 6.873 | 4.260 | 5.083 | 5.062 | 2.644 | 3.129 | 4.268 | 8.235 | 10.679 |
| Gross Profit/Loss - EUR | -7.983 | -6.571 | -2.027 | -4.419 | -1.087 | 1.277 | 789 | 7.209 | 4.766 | -3.527 |
| Net Profit/Loss - EUR | -7.984 | -6.579 | -2.095 | -4.439 | -1.206 | 1.159 | 672 | 6.864 | 3.613 | -3.630 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Training Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 52 | 0 | 579 | 2.681 | 3.054 | 2.555 | 2.067 | 1.667 | 1.781 | 10.066 |
| Current Assets | 1.054 | 399 | 258 | 250 | 1.121 | 2.719 | 3.684 | 11.779 | 8.731 | 1.707 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Receivables | 0 | 0 | 0 | 2 | 19 | 12 | 21 | 915 | 0 | 76 |
| Cash | 1.054 | 399 | 258 | 248 | 1.103 | 2.707 | 3.663 | 10.864 | 8.731 | 1.624 |
| Shareholders Funds | -7.939 | -14.438 | -16.288 | -20.428 | -21.238 | -19.676 | -18.568 | -11.761 | -14.177 | -17.728 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.045 | 14.837 | 17.125 | 23.359 | 25.413 | 24.950 | 24.319 | 25.207 | 24.690 | 29.501 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Pharma Training Srl